Related Experiment Video
Updated: Jan 17, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Aortic Atherosclerosis Detection on Transesophageal Echocardiography is Associated with Left Atrial Appendage
Samah AlKharji1, Mohamed Al Rawahi1, Ahmed AlTurki1
1Division of Cardiology, McGill University Health Centre Montreal, Quebec, Canada.
Insights
Aortic atherosclerosis (AA) predicts left atrial appendage thrombus (LAAT) in patients with low CHA2DS2-VASc scores. Assessing AA on transoesophageal echocardiography (TOE) may improve stroke risk stratification for atrial fibrillation (AF) patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Medical Imaging
Background:
- Elevated CHA2DS2-VASc scores predict left atrial appendage thrombus (LAAT), but low-risk individuals also face stroke risk.
- Aortic atherosclerosis (AA) is linked to increased stroke risk and has been overlooked in cardiovascular risk scores.
- Transoesophageal echocardiography (TOE) can visualize AA, a potentially significant 'vascular' variable.
Purpose of the Study:
- To determine the prevalence of LAAT in patients with low thromboembolic risk (CHA2DS2-VASc score ≤1).
- To investigate the correlation between aortic atherosclerosis (AA) and LAAT in this low-risk population.
- To evaluate AA as a predictor of LAAT in patients with low CHA2DS2-VASc scores.
Main Methods:
- Retrospective review of 592 transoesophageal echocardiograms (TOEs) from 2012-2017 for patients undergoing electrophysiology procedures.
- Assessment of aortic atherosclerosis (AA) using Katz score, ASE grade, and Ferrari score.
- Logistic regression and ROC curve analysis to identify LAAT predictors in patients with CHA2DS2-VASc score ≤1.
Main Results:
- Among 249 patients with CHA2DS2-VASc scores ≤1, 7.5% had LAAT.
- Aortic atherosclerosis (AA) burden, quantified by the Katz score, was an independent predictor of LAAT in patients with low CHA2DS2-VASc scores (AUC 0.76).
- AA visualized on TOE was significantly associated with increased LAAT risk in this low-risk group.
Conclusions:
- Aortic atherosclerosis (AA) detected by TOE is a significant predictor of left atrial appendage thrombus (LAAT) in patients with low CHA2DS2-VASc scores.
- Incorporating AA assessment into risk stratification may improve clinical decisions regarding anticoagulation for atrial fibrillation (AF) patients.
- Further research is needed to explore other imaging modalities for AA detection and its role in stroke risk assessment.
Background:
Elevated CHA2DS2-VASc scores are considered to be predictors of left atrial appendage (LAA) thrombus (LAAT); however, individuals with low scores remain at risk. Studies have indicated that aortic atherosclerosis (AA) is associated with increased stroke risk. AA on transoesophageal echocardiography (TOE) has been overlooked as a 'vascular' variable in the CHA2DS2-VASc score.
Aims:
Determine the prevalence of LAAT in patients with low thromboembolic risk and the correlation of AA with LAAT.
Methods:
We performed a retrospective review of all TOEs performed for patients who underwent electrophysiology procedures at the McGill University Health Centre from 2012 to 2017 and collected pertinent clinical and echocardiography variables. We reviewed all TOEs to evaluate the presence and severity of AA using the Katz score, American Society of Echocardiography (ASE) grade and the Ferrari score. In patients with a CHADS2 of 0 and CHA2DS2-VASc score of ≤1, logistical regression and receiver operating characteristic curves were used to identify predictors for LAAT.
Results:
592 patients underwent a pre-procedure TOE and were included in the analysis. Among 249 patients with CHA2DS2-VASc scores ≤1, 7.5% had LAA. AA burden by Katz score was an independent predictor of LAAT (area under the curve (AUC) 0.76 95% CI [0.60-0.92]) for CHA2DS2-VASc ≤1.
Conclusion:
AA visualised on TOE was significantly associated with an increased risk of LAAT development in patients with low CHA2DS2-VASc scores. Incorporating AA assessment into risk stratification may enhance clinical decision-making for the use of anticoagulation for patients with AF. Future studies are warranted to evaluate the use of other imaging modalities for AA detection.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation III: Medical Management
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

